Roubin
Gary Roubin, New York, NY US
Patent application number | Description | Published |
---|---|---|
20130178895 | SURGICALLY CLOSING PERCUTANEOUSLY PUNCTURES - A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire. | 07-11-2013 |
20130331921 | BIFURCATED CATHETER - Systems and methods are disclosed for a bifurcated catheter, and more particularly, to denervation of arterial nerves using a bifurcated catheter. In embodiments, the catheter comprises, for example, a catheter shaft bifurcated into a first catheter energy member and a second catheter energy member, wherein the first catheter energy member comprises a first transducer and the second catheter energy member comprises a second transducer, and wherein the first and second transducers are configured to cause denervation of an arterial nerve of the patient. | 12-12-2013 |
Gary Roubin, Jackson, WY US
Patent application number | Description | Published |
---|---|---|
20140065198 | Medical Implants and Methods for Regulating the Tissue Response to Vascular Closure Devices - Devices and methods for reducing, eliminating, preventing, suppressing, or treating tissue responses to hemostatic devices e.g., biological sealants or vascular procedures are disclosed. The invention employs a combination of resorbable, biocompatible matrix materials and a variety of therapeutic agents, such as antiproliferatives or antibiotics, applied to a vascular puncture or incision to achieve hemostasis following diagnostic or interventional vascular catheterizations and to treat neointimal hyperplasia and stenosis. A matrix of a material such as collagen provides a reservoir of a therapeutic agent such as rapamycin (sirolimus) and its derivatives and analogs for delivery at a tissue site at risk for vasculoproliferation, infection, inflammation, fibrosis or other tissue responses. | 03-06-2014 |
Gary S. Roubin, New York, NY US
Patent application number | Description | Published |
---|---|---|
20140350660 | Endoluminal Prosthesis - An endoluminal prosthesis for deployment in a body which has a first tubular structure for stabilising the prosthesis, the first tubular structure being substantially concentric about a first axis and movable between a compact and an expanded state. The prosthesis also has a second tubular structure for supporting an artificial heart valve, the second tubular structure being substantially concentric about a second axis and moveable between a compact and an expanded state. The first axis and the second axis extend at different angles when the first and second structures are in the compact and/or expanded state. A third structure which is shape and/or length adjustable is positioned between the first and second structures. | 11-27-2014 |